Clinical Trial: Single and Twice-daily Dosing of Ramipril on Renal Function in Chronic Kidney Disease Patients With Reduced Ejection Fraction Heart Failure

U.S., Dec. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07259512) titled 'Single and Twice-daily Dosing of Ramipril on Renal Function in Chronic Kidney Disease Patients With Reduced Ejection Fraction Heart Failure' on Nov. 20.

Brief Summary: This study compares the effects of once-daily versus twice-daily ramipril dosing on renal function in chronic kidney disease (CKD) patients with heart failure with reduced ejection fraction (HFrEF). Outcomes include changes in plasma renin activity, malondialdehyde, interleukin-6, albuminuria, and cystatin C after 30 days of therapy.

Study Start Date: June 30

Study Type: INTERVENTIONAL

Condition: Chronic Kidney Disease Heart Failure With Reduced Ejection Fraction (...